1. Home
  2. ACET vs JG Comparison

ACET vs JG Comparison

Compare ACET & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • JG
  • Stock Information
  • Founded
  • ACET 1947
  • JG 2012
  • Country
  • ACET United States
  • JG China
  • Employees
  • ACET N/A
  • JG N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • JG Computer Software: Programming Data Processing
  • Sector
  • ACET Health Care
  • JG Technology
  • Exchange
  • ACET Nasdaq
  • JG Nasdaq
  • Market Cap
  • ACET 70.3M
  • JG 57.5M
  • IPO Year
  • ACET N/A
  • JG 2018
  • Fundamental
  • Price
  • ACET $0.67
  • JG $10.06
  • Analyst Decision
  • ACET Buy
  • JG
  • Analyst Count
  • ACET 6
  • JG 0
  • Target Price
  • ACET $6.00
  • JG N/A
  • AVG Volume (30 Days)
  • ACET 312.0K
  • JG 63.2K
  • Earning Date
  • ACET 03-06-2025
  • JG 03-13-2025
  • Dividend Yield
  • ACET N/A
  • JG N/A
  • EPS Growth
  • ACET N/A
  • JG N/A
  • EPS
  • ACET N/A
  • JG N/A
  • Revenue
  • ACET N/A
  • JG $43,316,299.00
  • Revenue This Year
  • ACET N/A
  • JG $10.90
  • Revenue Next Year
  • ACET N/A
  • JG N/A
  • P/E Ratio
  • ACET N/A
  • JG N/A
  • Revenue Growth
  • ACET N/A
  • JG 8.94
  • 52 Week Low
  • ACET $0.67
  • JG $2.36
  • 52 Week High
  • ACET $2.40
  • JG $20.94
  • Technical
  • Relative Strength Index (RSI)
  • ACET 32.94
  • JG 48.55
  • Support Level
  • ACET $0.74
  • JG $10.01
  • Resistance Level
  • ACET $0.91
  • JG $10.72
  • Average True Range (ATR)
  • ACET 0.06
  • JG 0.63
  • MACD
  • ACET -0.01
  • JG -0.01
  • Stochastic Oscillator
  • ACET 0.36
  • JG 36.02

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, they gain access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

Share on Social Networks: